Jason S Roley, MD
Psychiatry · Redwood City
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 5
Offices
5 locations · Caminar · 7 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Roley’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A165015 · Current
Licensed to practise in California · since 2019 · expires 2027-08-31 · Drexel University College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$4,042
Medicare paid this office $4,042 for 12 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Who their Medicare patients are
12 Original Medicare patients in 2024. Average age 50 · 85 and older 0% · Also on Medicaid 100% · Health risk score 1.78. Above the middle of the specialty; the typical psychiatry clinician is at 1.35.
The office billed $24,109, Medicare allowed $5,393 and paid $4,042; for 38 services of 9 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Drugs they prescribed that Part D paid
$43,186
Pharmacies billed $43,186 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 239) in 2024. At or below the middle of the specialty; the typical psychiatry clinician is at 0%.
226 generic and 13 brand-name prescriptions · $43,186 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Olanzapine Odt | 28 | $1,918 | $68 |
| Divalproex | 11 | $398 | $36 |
| Trazodone | 12 | $280 | $23 |
| Gabapentin | 16 | $133 | $8 |
| Sertraline | 11 | $45 | $4 |
See all 6 drugs
| Olanzapine Odt | 28 | $1,918 | $68 |
| Divalproex | 11 | $398 | $36 |
| Trazodone | 12 | $280 | $23 |
| Gabapentin | 16 | $133 | $8 |
| Sertraline | 11 | $45 | $4 |
| Metformin | 11 | $44 | $4 |
Year by year
| 2024 | 239 | 16 | 0% (0) | 5% | $43,186 |
| 2023 | 23 | None | 0% (0) | 0% | $538 |
| 2022 | 183 | 14 | 0% (0) | 6% | $31,743 |
| 2021 | 149 | None | 0% (0) | None | $12,070 |
| 2020 | 55 | None | 0% (0) | None | $8,895 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2022: 3 drugs
| Divalproex | 17 | $633 | $37 |
| Duloxetine | 11 | $394 | $36 |
| Gabapentin | 24 | $362 | $15 |
2021: 8 drugs
| Naltrexone | 11 | $489 | $44 |
| Duloxetine | 11 | $398 | $36 |
| Hydroxyzine | 19 | $250 | $13 |
| Aripiprazole | 12 | $221 | $18 |
| Divalproex | 13 | $134 | $10 |
| Clonidine | 15 | $90 | $6 |
| Trazodone | 11 | $79 | $7 |
| Sertraline | 16 | $77 | $5 |
2020: 1 drug
| Hydroxyzine | 13 | $225 | $17 |
Money from drug and device companies
$15,779 in 2025
| 2025 | 1 | 11 | $15,330 | $15,779 |
| 2024 | 1 | 3 | None | $89 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Teva Pharmaceuticals USA | Uzedy | $15,779 | 11 payments
|
See all 11 published payments
| Teva Pharmaceuticals USA | Paid to speak or teach · 2025-11-30 | Uzedy | $420 |
| Teva Pharmaceuticals USA | Paid to speak or teach · 2025-08-06 | Uzedy | $2,380 |
| Teva Pharmaceuticals USA | Meals · 2025-08-06 | Uzedy | $24 |
| Teva Pharmaceuticals USA | Meals · 2025-04-23 | Uzedy | $117 |
| Teva Pharmaceuticals USA | Paid to speak or teach · 2025-04-23 | Uzedy | $4,200 |
| Teva Pharmaceuticals USA | Meals · 2025-04-21 | Uzedy | $12 |
| Teva Pharmaceuticals USA | Travel · 2025-04-21 | Uzedy | $171 |
| Teva Pharmaceuticals USA | Paid to speak or teach · 2025-04-21 | Uzedy | $3,570 |
| Teva Pharmaceuticals USA | Paid to speak or teach · 2025-04-02 | Uzedy | $2,380 |
| Teva Pharmaceuticals USA | Meals · 2025-02-20 | Uzedy | $125 |
| Teva Pharmaceuticals USA | Paid to speak or teach · 2025-02-20 | Uzedy | $2,380 |
See earlier years (2024)
2024: $89
| Teva Pharmaceuticals USA | Uzedy | $89 | 3 payments
|
Professional record
- NPI
- 1164913133
- Licence
- CA A165015California A165015: Current · expires 2027-08-31
- Trained
- Drexel University College of Medicine, 2018
- Group
- Caminar
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Psychiatry (2084P0800X)
- Mailing address
- 425 E Santa Clara St, San Jose, CA, 95113
- NPI first listed
- 2018-05-24
- NPI last updated
- 2024-01-29
- NPI record certified
- 2024-01-29
This is when the NPI record was last certified, not a medical board exam.